SCHEMBL21174659

SCHEMBL21174659

CC1Cc2cc(C(=O)O)ccc2CN1Cc1cccc(-c2nc3ccccc3[nH]2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.53
ALDH1A1 P00352 3/20 0.53
SMN1; SMN2 Q16637 3/20 0.53
HPGD P15428 2/20 0.53
NPC1 O15118 2/20 0.53
RAB9A P51151 2/20 0.53
KMT2A Q03164 4/20 0.45
PIM1 P11309 1/20 0.44
PIM3 Q86V86 1/20 0.44
AURKB Q96GD4 1/20 0.44
MMP2 P08253 3/20 0.44
MMP9 P14780 3/20 0.44
MMP8 P22894 3/20 0.44
MMP13 P45452 2/20 0.44
PDE4A P27815 3/20 0.43
PDE4B Q07343 3/20 0.43
PDE4C Q08493 3/20 0.43
PDE4D Q08499 3/20 0.43
MEN1 O00255 3/20 0.43
POLB P06746 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16147390 0.91 SMN1; SMN2 (0.50) KDM4EALDH1A1SMN1; SMN2HPGDNPC1
SCHEMBL16148105 0.88 PIM1 (0.47) KDM4EALDH1A1SMN1; SMN2HPGDNPC1
SCHEMBL16148299 0.84 KMT2A (0.43) KDM4EALDH1A1SMN1; SMN2HPGDNPC1
SCHEMBL16147923 0.84 NPC1 (0.46) KDM4EALDH1A1SMN1; SMN2HPGDNPC1
SCHEMBL16147236 0.83 PIM1 (0.42) KDM4EALDH1A1SMN1; SMN2HPGDNPC1
SCHEMBL16148357 0.83 PIM1 (0.42) KDM4EALDH1A1SMN1; SMN2HPGDNPC1
SCHEMBL16147347 0.82 PIM1 (0.44) KDM4EALDH1A1SMN1; SMN2HPGDNPC1
SCHEMBL16147266 0.80 KMT2A (0.45) KDM4EALDH1A1SMN1; SMN2HPGDNPC1
SCHEMBL16147482 0.80 PIM1 (0.43) KDM4EALDH1A1SMN1; SMN2HPGDNPC1
SCHEMBL16148268 0.79 PIM1 (0.42) KDM4EALDH1A1SMN1; SMN2HPGDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3514147-A1 STEROIDAL COMPOUNDS WITH POTENT ANDROGEN RECEPTOR DOWN-REGULATION AND ANTI PROSTATE CANCER ACTIVITY University of Maryland, Baltimore (US) 2019-07-24 EP disclosed